Chronicle Offers Management to Patients With Advanced Signs and Symptoms of Heart Failure - COMPASS-HF


The goal of this trial was to evaluate a strategy of heart failure management directed by an implantable continuous hemodynamic monitor (Chronicle device; Medtronic Inc., Minneapolis, MN) compared with optimal medical therapy in patients with advanced heart failure.